Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY:CAH)

150.55 +1.53 (+1.03%)
Streaming Delayed Price Updated: 9:57 AM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Wall Street Favorites: 3 Bargain Stocks With Strong Buy Ratings for April 2024
Buying value stocks can be a very profitable form of investing. These are a few great options for investors seeking discounted stocks. 
Via InvestorPlace
How Is The Market Feeling About Cardinal Health?
 
Via Benzinga
NYSE:CAH: good value for what you're paying.
CARDINAL HEALTH INC (NYSE:CAH) is probably undervalued for the fundamentals it is displaying. 
Via Chartmill
NYSE:CAH, a growth stock which is not overvalued.
For those who appreciate growth without the sticker shock, NYSE:CAH is worth considering. 
Via Chartmill
Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today
 
Via Benzinga
The Cash Cow Cavalry: 3 Stocks Leading the Charge to Profitability
Profitability drives a company's value in the market. These three stocks are headed toward stellar margins and profit growth! 
Via InvestorPlace
Here's How Much You Would Have Made Owning Cardinal Health Stock In The Last 5 Years
 
Via Benzinga
Peering Into Cardinal Health's Recent Short Interest
 
Via Benzinga
For those who appreciate growth without the sticker shock, NYSE:CAH is worth considering.
NYSE:CAH, a growth stock which is not overvalued. 
Via Chartmill
The 3 Most Undervalued Stocks With Solid Fundamentals to Buy in March 2024
Undervalued companies with strong fundamental are always a great addition to an investment due to their inherent upside potential. 
Via InvestorPlace
For those who appreciate value investing, NYSE:CAH is a compelling option with its solid fundamentals.
CARDINAL HEALTH INC (NYSE:CAH), an undervalued stock with good fundamentals. 
Via Chartmill
Cardinal Health Inc. (NYSE: CAH) Sets New 52-Week High in Tuesday Session
Via Investor Brand Network
3 Top-Ranked Stocks To Buy For Stability
Low-beta stocks can provide several beneficial advantages for portfolios, including defensive qualities and stabilization when combined with high-beta stocks, helping to provide a more balanced risk... 
Via Talk Markets
3 Stocks to Buy at 52-Week Lows: March 4 Edition
Sometimes a gem can get tossed in the trash, which is what you will find with these three stocks to buy at 52-week lows. 
Via InvestorPlace
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
 
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
 
Via Benzinga
Earnings Preview: Cardinal Health
 
Via Benzinga
Here's How Much You Would Have Made Owning Cardinal Health Stock In The Last 5 Years
 
Via Benzinga
Shake Shack, Cardinal Health And More: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said she likes Invesco S&P 500 Equal Weight Energy ETF (NYSE: 
Via Benzinga
Topics ETFs
Dividend Income Update January 2024
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio 
Via Talk Markets
Cardinal Health Stock Shows Healthy Improvement To Its Technical Strength
On Wednesday, Cardinal Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 69 to 78. 
Via Investor's Business Daily
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices. 
Via Benzinga
Why Is Healthcare Services Provider Cardinal Health Stock Trading Lower Today?
Cardinal Health reports strong Q2 FY24 results: Adjusted EPS up 38% to $1.82, beating consensus. Q2 revenue for pharmaceutical segment rises 12% to $53.5 billion. Raised FY24 EPS guidance to... 
Via Benzinga
Nasdaq Futures Rebound As Traders Eye Apple, Meta, Amazon Earnings: Analyst Flags 'January Barometer' That Bodes Well For The Year
After ending January with modest gains, the major averages now look to earnings catalysts to drive momentum, with futures higher in first trading session of February. 
Via Benzinga
Cardinal Health Inc. (NYSE: CAH) Climbs to New 52-Week High
Via Investor Brand Network
3 Top-Ranked Large-Caps To Buy For Growth
Large-cap stocks are frequently targeted among investors. They typically have greater stability and a proven track record, two reasons why they're beloved. 
Via Talk Markets
2023 Year-End Sector Review – Part 2
In this 2023 year-end sector review, we will take a look at what kind of year it was for healthcare, industrial, technology, materials, REITs, and utility sectors. Additionally, how is 2024 shaping up... 
Via Talk Markets
Earnings Scheduled For February 1, 2024
Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on... 
Via Benzinga
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending. 
Via Benzinga
Topics Artificial Intelligence
Dow Resumes Selloff, Set To Snap Win Streak
Stocks have resumed their trek lower in what has become an alarming trend to start 2024. 
Via Talk Markets
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.